Cardiff Oncology Inc (CRDF)

Track

Stock chart
Ticker: CRDF Exchange: NAS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-18 2024-12-18 B Purchase

Levine James E.

Chief Financial Officer

Officer
2,400 +3.7%
5.00
USD 12,000 		2,400 +3.7% 5.00 USD 12,000
2024-12-18 2024-12-17 B Purchase

Levine James E.

Chief Financial Officer

Officer
2,752 +4.4%
5.42
USD 14,905 		2,752 +4.4% 5.42 USD 14,905
2024-12-18 2024-12-16 B Purchase

Levine James E.

Chief Financial Officer

Officer
2,564 +4.3%
3.83
USD 9,820 		2,564 +4.3% 3.83 USD 9,820
2024-12-16 2024-12-12 B Purchase

TANNENBAUM RENEE P

Non-Executive Director
10,000 +100.0%
3.42
USD 34,224 		10,000 +100.0% 3.42 USD 34,224
2024-12-12 2024-12-11 B Purchase

PACE GARY W

Non-Executive Director
11,500 +1.1%
2.60
USD 29,900 		11,500 +1.1% 2.60 USD 29,900
2024-12-12 2024-12-11 B Purchase

PACE GARY W

Non-Executive Director
350,115 +50.2%
2.60
USD 910,299 		350,115 +50.2% 2.60 USD 910,299
2023-12-19 2023-12-19 B Purchase

PACE GARY W

Non-Executive Director
30,000 +4.5%
1.37
USD 41,100 		30,000 +4.5% 1.37 USD 41,100
2023-11-14 2023-11-10 B Purchase

PACE GARY W

Non-Executive Director
22,950 +3.6%
0.98
USD 22,491 		22,950 +3.6% 0.98 USD 22,491
2022-11-29 2022-11-25 B Purchase

Erlander Mark

Chief Executive Officer

Executive Director
10,000 +69.1%
1.43
USD 14,300 		10,000 +69.1% 1.43 USD 14,300
2022-09-20 2022-09-19 B Purchase

White Lale

Non-Executive Director
15,000 +15.2%
1.64
USD 24,525 		15,000 +15.2% 1.64 USD 24,525
2022-10-11 2022-09-16 B Purchase

Armitage James O

Non-Executive Director
13,000 +inf%
1.56
USD 20,233 		13,000 +inf% 1.56 USD 20,233
2022-09-19 2022-09-16 B Purchase

Levine James E.

Chief Financial Officer

Officer
30,000 +100.0%
1.56
USD 46,710 		30,000 +100.0% 1.56 USD 46,710
2022-09-19 2022-09-15 B Purchase

TANNENBAUM RENEE P

Non-Executive Director
3,600 +56.2%
1.72
USD 6,192 		3,600 +56.2% 1.72 USD 6,192
2022-09-19 2022-09-15 B Purchase

TANNENBAUM RENEE P

Non-Executive Director
6,400 +inf%
1.72
USD 10,976 		6,400 +inf% 1.72 USD 10,976
2022-09-19 2022-09-15 B Purchase

PACE GARY W

Non-Executive Director
150,000 +30.3%
1.71
USD 256,500 		150,000 +30.3% 1.71 USD 256,500
2021-09-13 2021-09-10 B Purchase

Levine James E.

Chief Financial Officer

Officer
5,000 +20.0%
6.32
USD 31,600 		5,000 +20.0% 6.32 USD 31,600
2021-09-13 2021-09-10 B Purchase

Levine James E.

Chief Financial Officer

Officer
5,000 +25.0%
6.35
USD 31,750 		5,000 +25.0% 6.35 USD 31,750
2021-09-13 2021-09-10 B Purchase

Levine James E.

Chief Financial Officer

Officer
10,000 +100.0%
6.38
USD 63,800 		10,000 +100.0% 6.38 USD 63,800
2021-09-13 2021-09-10 B Purchase

Levine James E.

Chief Financial Officer

Officer
5,000 +100.0%
6.75
USD 33,750 		5,000 +100.0% 6.75 USD 33,750
2021-09-13 2021-09-10 B Purchase

Levine James E.

Chief Financial Officer

Officer
5,000 +inf%
6.62
USD 33,100 		5,000 +inf% 6.62 USD 33,100
// ... existing code ...